Paperpal Prime Logo

European Respiratory Journal : Impact Factor & More

eISSN: 1399-3003pISSN: 0903-1936

Key Metrics

CiteScore
18.9
Eigenfactor
0.05 - 0.1
H-Index
267
Impact Factor
20 - 25
Scite Index
0.87 5-Year SI
SJR
Q1Medicine (miscellaneous)
SNIP
3.69
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on European Respiratory Journal

European Respiratory Journal Journal Specifications

Overview
Publisher EUROPEAN RESPIRATORY SOC JOURNALS LTD
Language English
Frequency Monthly
General Details
LanguageEnglish
FrequencyMonthly
Publication Start Year1988
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in European Respiratory Journal ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in European Respiratory Journal

Characterization of Airway Morphology in Post-infectious versus Post-lung Transplant Bronchiolitis Obliterans.
  • 6 Aug 2026
  • The European respiratory journal
A phase 2a, double-blind, randomised, placebo-controlled trial of the myeloperoxidase inhibitor, mitiperstat, in participants with chronic obstructive pulmonary disease.
  • 6 Aug 2026
  • The European respiratory journal
Association of Positive airway pressure adherence with mortality and cardiovascular events in high vs low risk sleep apnoea patients.
  • 6 Aug 2026
  • The European respiratory journal
SARS-CoV-2 E protein induces rapid TLR2-mediated T cell activation in mouse lungs revealed by intravital lung microscopy
  • 6 Aug 2026
  • The European Respiratory Journal
Improved Outcomes with Early Aggressive Therapy in Pediatric Pulmonary Hypertension.
  • 6 Aug 2026
  • The European respiratory journal
The use of spirometry to define airflow obstruction and diagnose COPD
  • 6 Aug 2026
  • The European Respiratory Journal
Characterization of Airway Morphology in Post-infectious versus Post-lung Transplant Bronchiolitis Obliterans.
  • 6 Aug 2026
  • The European respiratory journal
A phase 2a, double-blind, randomised, placebo-controlled trial of the myeloperoxidase inhibitor, mitiperstat, in participants with chronic obstructive pulmonary disease.
  • 6 Aug 2026
  • The European respiratory journal
Association of Positive airway pressure adherence with mortality and cardiovascular events in high vs low risk sleep apnoea patients.
  • 6 Aug 2026
  • The European respiratory journal
SARS-CoV-2 E protein induces rapid TLR2-mediated T cell activation in mouse lungs revealed by intravital lung microscopy
  • 6 Aug 2026
  • The European Respiratory Journal
Improved Outcomes with Early Aggressive Therapy in Pediatric Pulmonary Hypertension.
  • 6 Aug 2026
  • The European respiratory journal
The use of spirometry to define airflow obstruction and diagnose COPD
  • 6 Aug 2026
  • The European Respiratory Journal

FAQs on European Respiratory Journal